Skip to Main Content

Author Details

Zachary L Skidmore
Washington University in St. Louis School of Medicine
2015
48
20
PMIDPaper TitleJournal TitlePublished Year
36251745Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma.Blood Adv2023
37910143Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma.Cancer Res Commun2023
37487666Autologous humanized PDX modeling for immuno-oncology recapitulates features of the human tumor microenvironment.J Immunother Cancer2023
37493986Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.Blood Adv2023
37810214Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer.iScience2023
36949070Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer.Nat Commun2023
37034778Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer.bioRxiv2023
37266381Genomic landscape and gene expression profiles of feline oral squamous cell carcinoma.Front Vet Sci2023
36373660CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase.Nucleic Acids Res2023
34780623Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma.Blood2022
35494251Integrative genomic analysis reveals low T-cell infiltration as the primary feature of tobacco use in HPV-positive oropharyngeal cancer.iScience2022
35568002Genomic and transcriptomic somatic alterations of hepatocellular carcinoma in non-cirrhotic livers.Cancer Genet2022
35624339A community approach to the cancer-variant-interpretation bottleneck.Nat Cancer2022
36273232Personalized ctDNA micro-panels can monitor and predict clinical outcomes for patients with triple-negative breast cancer.Sci Rep2022
34610950Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis.Cancer Discov2022
33397681Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.Clin Cancer Res2021
35611186<i>In silico</i> epitope prediction analyses highlight the potential for distracting antigen immunodominance with allogeneic cancer vaccines.Cancer Res Commun2021
33547198Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas.Clin Cancer Res2021
33556121Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches.PLoS One2021
34506690Exploring the Genomic Landscape of Cancer Patient Cohorts with GenVisR.Curr Protoc2021
34019588Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCF.PLoS Pathog2021
34036230Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia.JCO Precis Oncol2021
34173924Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer.Breast Cancer Res Treat2021
32665297Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.Clin Cancer Res2020
31902496A virome sequencing approach to feline oral squamous cell carcinoma to evaluate viral causative factors.Vet Microbiol2020
30287923Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples.Genet Med2019
31685621Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.Proc Natl Acad Sci U S A2019
31467059Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade.Blood2019
31390566A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation.Cell Rep2019
31618044Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes.JCO Clin Cancer Inform2019
30429476Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer.Nat Commun2018
30134176Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular Heterogeneity.Cell Rep2018
29891591A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel <i>RARG</i>-<i>CPSF6</i> fusion.Blood Adv2018
30181556The prognostic effects of somatic mutations in ER-positive breast cancer.Nat Commun2018
30224629Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer.Nat Commun2018
28874413A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i>-Mutant ER-Positive and HER2-Negative Breast Cancer.Clin Cancer Res2017
28138153CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer.Nat Genet2017
28434888Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.Bone2017
28270497NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.Clin Cancer Res2017
27029710A genomic case study of mixed fibrolamellar hepatocellular carcinoma.Ann Oncol2016
26563128A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer.Clin Cancer Res2016
26531824DGIdb 2.0: mining clinically relevant drug-gene interactions.Nucleic Acids Res2016
27681435Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas.Cell Rep2016
27288499GenVisR: Genomic Visualizations in R.Bioinformatics2016
27181063Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia.Exp Hematol2016
27058228A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML.Blood Cancer J2016
26158448Genome Modeling System: A Knowledge Management Platform for Genomics.PLoS Comput Biol2015
26645048Optimizing cancer genome sequencing and analysis.Cell Syst2015
  • 1 - 48 of 48

Recommended Authors

Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Career Start Year 2016
Number of shared co-authors 4
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 5
Washington University in St Louis
Career Start Year 2015
Number of shared co-authors 26
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 1
The Hong Kong University of Science and Technology
Career Start Year 2012
Number of shared co-authors 0
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 3
Abbvie Inc., Genomics Research Center
Career Start Year 2009
Number of shared co-authors 1
University of Bern
Career Start Year 2009
Number of shared co-authors 3
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 17
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 1
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 0
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 5
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 4
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 6
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 3
St Vincent's Hospital Melbourne
Career Start Year 2006
Number of shared co-authors 3
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 16
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 4
University of Augsburg
Career Start Year 2004
Number of shared co-authors 5
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 13
University of California
Career Start Year 2003
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 22
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 4
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 7
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 0
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 36
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 22

Collaborators

Washington University
Co-authored papers 47
Washington University
Co-authored papers 46
Washington University School of Medicine
Co-authored papers 22
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 20
The Ohio State University
Co-authored papers 19
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 16
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 15
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 11
Washington University
Co-authored papers 10
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 10
The Ohio State University
Co-authored papers 10
Washington University School of Medicine
Co-authored papers 10
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 10
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 9
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 9
The Ohio State University
Co-authored papers 9
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Co-authored papers 8
Washington University
Co-authored papers 8
Iowa State University, Mayo Clinic, Nationwide Children's Hospital, The Ohio State University College of Medicine, University of Iowa, Washington University in Saint Louis
Co-authored papers 8
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 8
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 8
Washington University School of Medicine
Co-authored papers 8
Co-authored papers 7
Washington University School of Medicine in St. Louis
Co-authored papers 6
Brigham and Women's Hospital
Co-authored papers 6
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 5
Washington University in St Louis
Co-authored papers 5
Washington University School of Medicine
Co-authored papers 5
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 5
Washington University
Co-authored papers 5